SCHEMBL20016486

SCHEMBL20016486

CC(C)CCC(=O)NCC(C)CC(C)CC(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
ANPEP P15144 3/20 0.38
CA1 P00915 2/20 0.38
DNPEP Q9ULA0 2/20 0.38
RNPEP Q9H4A4 2/20 0.35
HPGD P15428 2/20 0.35
PSMB5 P28074 2/20 0.34
P2RX7 Q99572 1/20 0.34
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 1/20 0.33
PKM P14618 1/20 0.33
NEU1 Q99519 1/20 0.33
NEU3 Q9UQ49 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP12 P39900 1/20 0.33
MMP14 P50281 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23626511 0.84 ANPEP (0.41) ALDH1A1ANPEPCA1DNPEPRNPEP
SCHEMBL19818505 0.81 ALDH1A1 (0.44) ALDH1A1CA1HPGDP2RX7CYP2D6
SCHEMBL9349283 0.80 CYP2D6 (0.52) ALDH1A1CA1HPGDCYP2D6CYP2C19
SCHEMBL22912616 0.79 ALDH1A1 (0.42) ALDH1A1ANPEPCA1DNPEPRNPEP
SCHEMBL18769009 0.77 SMN1; SMN2 (0.39) ALDH1A1HPGDPSMB5CYP2D6CYP2C19
SCHEMBL24391761 0.75 ALDH1A1 (0.45) ALDH1A1ANPEPCA1DNPEPHPGD
SCHEMBL23106272 0.74 HPGD (0.45) ALDH1A1HPGDCYP2D6CYP2C19LMNA
SCHEMBL21658063 0.73 ALDH1A1 (0.52) ALDH1A1ANPEPCA1DNPEPRNPEP
SCHEMBL19818495 0.73 CYP2D6 (0.45) ALDH1A1CA1HPGDPSMB5CYP2D6
SCHEMBL24450393 0.73 HPGD (0.38) ALDH1A1HPGDPSMB5EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11312964-B2 Compositions and methods for modulating growth hormone receptor expression IONIS PHARMACEUTICALS, INC. (US) 2022-04-26 US disclosed
US-20210207146-A1 COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION IONIS PHARMACEUTICALS, INC. (US) 2021-07-08 US disclosed
US-9957292-B2 Compositions and methods for modulating angiopoietin-like 3 expression IONIS PHARMACEUTICALS, INC. (US) 2018-05-01 US disclosed
US-9932581-B2 Compositions and methods for modulating apolipoprotein C-III expression IONIS PHARMACEUTICALS, INC. (US) 2018-04-03 US disclosed